Sign inGet started

AHMED NADIM

Insider CIK 1731193 · BMY President, Hematology · CGEM President and CEO, Director · IRON Director · CELG PRES., HEMATOLOGY AND ONCOLOGY

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IRON Disc Medicine, Inc. A Award deriv2026-06-182026-06-235,176— $05,176SEC↗
CGEM Cullinan Therapeutics, Inc S Sale2026-02-242026-02-2513,515$14.47 $195.6K390,803SEC↗
CGEM Cullinan Therapeutics, Inc S Sale2026-02-202026-02-2316,381$13.62 $223.1K404,318SEC↗
CGEM Cullinan Therapeutics, Inc A Award deriv2026-02-182026-02-19828,000— $0828,000SEC↗
CGEM Cullinan Therapeutics, Inc S Sale2025-12-232025-12-299,922$10.01 $99.3K420,699SEC↗
IRON Disc Medicine, Inc. A Award deriv2025-07-142025-07-1620,000— $020,000SEC↗
CGEM Cullinan Therapeutics, Inc S Sale2025-02-252025-02-2712,529$8.53 $106.9K430,621SEC↗
CGEM Cullinan Therapeutics, Inc A Award deriv2025-02-192025-02-21360,000— $0360,000SEC↗
CGEM Cullinan Therapeutics, Inc A Award2025-02-192025-02-21180,000— $0443,150SEC↗
CGEM Cullinan Therapeutics, Inc S Sale2024-12-242024-12-278,400$11.87 $99.7K263,150SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2024-02-222024-02-23320,000— $0320,000SEC↗
CGEM Cullinan Oncology, Inc. A Award2024-02-222024-02-23160,000— $0271,550SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-12-262023-12-274,272$9.24 $39.5K111,550SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-06-282023-06-29759$11.40 $8.7K115,822SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-05-232023-05-24707$9.15 $6.5K116,581SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-04-252023-04-26716$10.59 $7.6K117,288SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-03-232023-03-27706$10.51 $7.4K118,004SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2023-02-222023-02-23211,000— $0211,000SEC↗
CGEM Cullinan Oncology, Inc. A Award2023-02-222023-02-23109,000— $0118,710SEC↗
CGEM Cullinan Oncology, Inc. A Award2022-06-302022-07-051,620$10.90 $17.7K9,710SEC↗
CGEM Cullinan Oncology, Inc. P Buy2022-06-062022-06-078,090$12.40 $100.3K8,090SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2022-03-052022-03-07215,000— $0215,000SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2021-10-182021-10-202,710,000— $02,710,000SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise deriv2020-12-312021-01-0514,946— $00SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise2020-12-312021-01-0514,946— $046,549SEC↗
BMY BRISTOL MYERS SQUIBB CO F Tax w/h2020-12-312021-01-057,660$62.03 $475.1K38,889SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise deriv2020-12-022020-12-036,594— $019,782SEC↗
BMY BRISTOL MYERS SQUIBB CO F Tax w/h2020-12-022020-12-033,380$62.18 $210.2K31,603SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise2020-12-022020-12-036,594— $034,983SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise deriv2020-10-302020-11-034,650— $00SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise2020-10-302020-11-034,650— $030,680SEC↗
BMY BRISTOL MYERS SQUIBB CO F Tax w/h2020-10-302020-11-032,291$58.45 $133.9K28,389SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise deriv2020-05-012020-05-052,908— $00SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise2020-05-012020-05-052,908— $027,463SEC↗
BMY BRISTOL MYERS SQUIBB CO F Tax w/h2020-05-012020-05-051,433$60.26 $86.4K26,030SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2020-03-102020-03-1232,082— $032,082SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2020-03-102020-03-1221,388— $021,388SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise deriv2020-03-012020-03-0317,204— $034,410SEC↗
BMY BRISTOL MYERS SQUIBB CO F Tax w/h2020-03-012020-03-038,473$59.06 $500.4K24,555SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise2020-03-012020-03-0317,204— $033,028SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise deriv2020-02-042020-02-062,076— $04,152SEC↗
BMY BRISTOL MYERS SQUIBB CO M Exercise2020-02-042020-02-062,076— $016,895SEC↗
BMY BRISTOL MYERS SQUIBB CO F Tax w/h2020-02-042020-02-061,071$64.29 $68.9K15,824SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-12-022019-12-0426,376— $026,376SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202020-01-0314,946— $014,946SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202020-01-0333,183— $033,183SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,125— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,125— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-227,500— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-224,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,626— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-229,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,626— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,624— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-221,750— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-226,562— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-2210,548— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,348— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,125— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,000— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-2210,548— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-2227,749— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-2210,549— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-221,563— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-222,500— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-225,357— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-226,563— $00SEC↗
CELG CELGENE CORP /DE/ D To issuer deriv2019-11-202019-11-223,125— $00SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-277,440— $07,440SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-276,975— $06,975SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-276,975— $06,975SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-276,974— $06,974SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2710,463— $010,463SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2716,740— $016,740SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2710,464— $010,464SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2710,460— $010,460SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-273,255— $03,255SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-272,908— $02,908SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2719,621— $019,621SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2719,619— $019,619SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2719,619— $019,619SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,299— $09,299SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,300— $09,300SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-275,843— $05,843SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-275,843— $05,843SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2712,272— $012,272SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2712,205— $012,205SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-275,843— $05,843SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-275,812— $05,812SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,299— $09,299SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,350— $09,350SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,350— $09,350SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,350— $09,350SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-277,012— $07,012SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,350— $09,350SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-276,975— $06,975SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2713,949— $013,949SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-276,974— $06,974SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-279,965— $09,965SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2751,614— $051,614SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-276,228— $06,228SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2733,182— $033,182SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-2714,945— $014,945SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award deriv2019-11-202019-11-274,650— $04,650SEC↗
CELG CELGENE CORP /DE/ D To issuer2019-11-202019-11-221,966— $00SEC↗
CELG CELGENE CORP /DE/ A Award2019-11-202019-11-228,035— $022,854SEC↗
CELG CELGENE CORP /DE/ A Award2019-11-202019-11-2217,840— $040,694SEC↗
CELG CELGENE CORP /DE/ D To issuer2019-11-202019-11-2240,694— $00SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award2019-11-202019-11-2714,819— $014,819SEC↗
BMY BRISTOL MYERS SQUIBB CO A Award2019-11-202019-11-271,966— $01,966SEC↗
CELG CELGENE CORP /DE/ M Exercise deriv2019-10-312019-11-043,281— $00SEC↗
CELG CELGENE CORP /DE/ M Exercise2019-10-312019-11-043,281— $015,915SEC↗
CELG CELGENE CORP /DE/ F Tax w/h2019-10-312019-11-041,096$108.03 $118.4K14,819SEC↗
CELG CELGENE CORP /DE/ M Exercise deriv2019-05-022019-05-061,563— $00SEC↗
CELG CELGENE CORP /DE/ F Tax w/h2019-05-022019-05-06490$95.21 $46.7K12,634SEC↗
CELG CELGENE CORP /DE/ M Exercise2019-05-022019-05-061,563— $013,124SEC↗
CELG CELGENE CORP /DE/ A Award deriv2019-03-012019-03-0527,749— $027,749SEC↗
CELG CELGENE CORP /DE/ A Award deriv2019-02-042019-02-063,348— $03,348SEC↗
CELG CELGENE CORP /DE/ M Exercise deriv2018-12-162018-12-183,000— $00SEC↗
CELG CELGENE CORP /DE/ F Tax w/h2018-12-162018-12-181,477$68.20 $100.7K11,561SEC↗
CELG CELGENE CORP /DE/ M Exercise2018-12-162018-12-183,000— $013,038SEC↗
CELG CELGENE CORP /DE/ A Award deriv2018-10-292018-10-3110,549— $010,549SEC↗
CELG CELGENE CORP /DE/ A Award deriv2018-07-302018-08-0110,548— $010,548SEC↗